Adverse Effects of Predictive Testing for Huntington Disease Underestimated: Long-Term Effects 7-10 Years after the Test

Health Psychology

Volumn 23, Issue 2, 2004, Pages 189-197

  Timman, Reinier ^a,b   Roos, Raymund ^a   Maat Kievit, Anneke ^b   Tibben, Aad ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Distress; DNA testing; Dropout; Huntington disease; Long term follow up

Indexed keywords

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; DENIAL; DISTRESS SYNDROME; FEMALE; FOLLOW UP; GENETIC SCREENING; HEALTH STATUS; HETEROZYGOTE DETECTION; HUMAN; HUNTINGTON CHOREA; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RATING SCALE; SPOUSE;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HETEROZYGOTE; HUMANS; HUNTINGTON DISEASE; MALE; MOLECULAR BIOLOGY; PATIENT DROPOUTS; PREDICTIVE VALUE OF TESTS; PSYCHOLOGICAL TESTS; QUESTIONNAIRES; TIME; TIME FACTORS;

EID: 1642329097     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.23.2.189     Document Type: Article

References (33)

1. Beck, A. T., & Steer, R. A. (1989). Clinical predictors of eventual suicide: A 5- to 10-year prospective study of suicide attempters. Journal of Affective Disorders, 17, 203-209.
2. Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974). The measurement of pessimism: The hopelessness scale. Journal of Consulting and Clinical Psychology, 42, 861-865.
3. Bijleveld, C. C. J. H., van der Kamp, L. T., Mooijaart, A., van der Kloot, W. A., van der Leeden, R., & van der Burg, E. (Eds.). (1999). Longitudinal data analysis: Designs, models and methods. London: Sage.
4. Brinkman, R. R., Mezei, M. M., Theilmann, J., Almqvist, E., & Hayden, M. R. (1997). The likelihood of being affected with Huntington disease by a particular age, for a specific CAG repeat. American Journal of Human Genetics, 60, 1202-1210.
5. Broadstock, M., Michie, S., & Marteau, T. M. (2000). The psychological consequences of predictive genetic testing: A systematic review. European Journal of Human Genetics, 8, 731-738.
6. Bundey, S. (1997). Few psychological consequences of presymptomatic testing for Huntington disease. Lancet, 349(9044), 4.
7. Codori, A.-M., Slavney, P. R., Young, C., Miglioretti, D. L., & Brandt, J. (1997). Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychology, 16, 36-50.
8. Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., et al. (1996). Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making. Journal of Medical Genetics, 33, 737-743.
9. Duisterhof, M., Trijsburg, R. W., Niermeijer, M. F., Roos, R. A. C., & Tibben, A. (2001). Psychological studies on Huntington's disease: Making up the balance. Journal of Medical Genetics, 38, 852-861.
10. Goldberg, D. P. (1972). The detection of psychiatric illness by questionnaire. London: Oxford University Press.
11. Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., et al. (1983). A polymorphic DNA marker genetically linked to Huntington's disease. Nature, 306, 234-238.
12. Harper, P. S. (Ed.). (1996). Huntington's disease. London: Saunders.
13. HD Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
14. Horowitz, M. J., Field, N. P., Zanko, A., Donnelly, E. F., Epstein, C., & Longo, F. (2001). Psychological impact of news of genetic risk for Huntington disease. American Journal of Medical Genetics, 103, 188-192.
15. Horowitz, M. J., Wilner, N., & Alvarez, W. (1979). Impact of Event Scale: A measure of subjective stress. Psychosomatic Medicine, 41, 209-218.
16. International Huntington Association and World Federation of Neurology Research Group on Huntington's Chorea. (1990). Ethical issues policy statement on Huntington's disease molecular genetics predictive test. Journal of Medical Genetics, 27, 34-38.
17. International Huntington Association and World Federation of Neurology Research Group on Huntington's Chorea. (1994). Guidelines for the molecular genetics predictive test in Huntington's disease. Journal of Medical Genetics, 31, 555-559.
18. Kessler, S., Field, T., Worth, L., & Mosbarger, H. (1987). Attitudes of persons at risk for Huntington disease toward predictive testing. American Journal of Medical Genetics, 26, 259-270.
19. Lawson, K., Wiggins, S., Green, T., Adam, S., Bloch, M., Hayden, M., et al. (1996). Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. Journal of Medical Genetics, 3, 856-862.
20. Little, R. J. A., & Rubin, D. B. (1987). Statistical analysis with missing data. New York: Wiley.
21. Maat-Kievit, A., Losekoot, M., Zwinderman, K., Vegter-van der Vlis, M., Belfroid, R., Lopez, F., et al. (in press). Predictability of age at onset in Huntington disease in the Dutch population. Medicine, 81, 251-259.
22. Markel, D. S., Young, A. B., & Penney, J. B. (1987). At risk persons' attitude toward presymptomatic and prenatal testing of Huntington disease in Michigan. American Journal of Medical Genetics, 26, 295-305.
23. Meiser, B., & Dunn, S. (2000). Psychological impact of genetic testing for Huntington disease: An update of the literature. Journal of Neurology, Neurosurgery & Psychiatry, 69, 574-578.
24. Meiser, B., Gleeson, M. A., & Tucker, K. M. (2000). Psychological impact of genetic testing for adult-onset disorders. An update for clinicians. Medical Journal of Australia, 172, 126-129.
25. Meissen, G. J., & Berchek, R. L. (1987). Intended use of predictive testing by those at risk for Huntington disease. American Journal of Medical Genetics, 26, 283-293.
26. Quaid, K. A., & Wesson, M. K. (1995). Exploration of the effects of predictive testing for Huntington Disease on intimate relationships. American Journal of Medical Genetics, 57, 46-51.
27. Tibben, A. (1993). What is knowledge but grieving? On the psychological effects of presymptomatic DNA-testing for Huntington's disease. Unpublished doctoral dissertation, Erasmus University, Rotterdam, the Netherlands.
28. Tibben, A., Duivenvoorden, H. J., Niermeijer, M. F., Vegter-van der Vlis, M., Roos, R. A. C., & Verhage, F. (1994). Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. Psychosomatic Medicine, 56, 526-532.
29. Tibben, A., Frets, P. G., Van De Kamp, J. J. P., Niermeyer, M. F., Vegter-Van Der Vlis, M., Roos, R. A. C., et al. (1993). Presymptomatic DNA testing for HD: Pretest attitudes and expectations of applicants and their partners in the Dutch program. American Journal of Medical Genetics, 48, 10-16.
30. Tibben, A., Timman, R., Bannink, E. C., & Duivenvoorden, H. J. (1997). Three year follow up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychology, 16, 20-35.
31. Tibben, A., Vegter-van der Vlis, M., Skraastad, M. I., Frets, P. G., Van de Kamp, J. J. P., Niermeijer, M. F., et al. (1992). DNA-testing for Huntington's disease in the Netherlands: A retrospective study on psychosocial effects. American Journal of Medical Genetics, 44, 94-99.
32. Timman, R., Maat-Kievit, A., Brouwer-DudokdeWit, C., Zoeteweij, M., Breuning, M. H., & Tibben, A. (2003). Testing the test - Why pursue a better test for Huntington disease? American Journal of Medical Genetics, 117B, 79-85.
33. Verbeke, G., & Molenberghs, G. (Eds.). (1997). Linear mixed models in practice - A SAS oriented approach (Vol. 126). New York: Springer.